Investors File Class Action Lawsuit Against Unicycive Therapeutics, Inc. to Recoup Losses

A class-action lawsuit has been initiated against Unicycive Therapeutics, Inc. (UNCY), urging individuals to take action to recover losses before the deadline of October 14, 2025. The lawsuit targets the company for alleged violations of federal securities laws and failure to disclose crucial information that could have impacted investors’ decisions.

Investors who suffered losses from investing in Unicycive Therapeutics, Inc. (UNCY) between February 7, 2024, and September 12, 2025, are encouraged to contact Levi & Korsinsky to participate in the lawsuit. The filing of the lawsuit comes after an investigation into the company’s activities during the specified timeframe, uncovering potential misconduct and misleading practices by Unicycive Therapeutics.

Individuals who purchased Unicycive Therapeutics, Inc. (UNCY) shares during the identified period may have been affected by the company’s actions that violated federal securities laws. By failing to disclose critical information that could have influenced investors’ decisions, Unicycive Therapeutics may have caused financial harm to shareholders who relied on accurate and transparent disclosures.

The class-action lawsuit seeks to hold Unicycive Therapeutics, Inc. (UNCY) accountable for any damages incurred by investors due to the company’s alleged violations. By joining the lawsuit before the October 14, 2025, deadline, affected individuals may have the opportunity to recover their losses and seek justice for any harm suffered as a result of Unicycive Therapeutics’ actions.

Investors who believe they have been impacted by the company’s misconduct or misleading practices are urged to contact Levi & Korsinsky to explore their legal options and participate in the class-action lawsuit. By taking action before the specified deadline, investors can actively seek compensation for any losses incurred and contribute to holding Unicycive Therapeutics accountable for its alleged wrongdoing.

In conclusion, the class-action lawsuit against Unicycive Therapeutics, Inc. (UNCY) provides affected investors with the opportunity to recover losses incurred during the specified period. By contacting Levi & Korsinsky before October 14, 2025, individuals can join the lawsuit and seek justice for any harm suffered due to the company’s alleged violations of federal securities laws. Taking timely action is crucial for investors looking to recover their losses and hold Unicycive Therapeutics accountable for its actions.